Results: 5

    Ongoing living update of potential COVID-19 therapeutics: summary of rapid systematic reviews - 25 March 2021

    The urgent need for evidence on measures to respond to the COVID-19 pandemic had led to a rapid escalation in numbers of studies testing potential therapeutic options. The vast amount of data generated by these studies must be interpreted quickly so that physicians have the information to make optimal tr...

    Ongoing living update of potential COVID-19 therapeutics: summary of rapid systematic reviews - 22 September 2020

    As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In thi...

    Ongoing living update of potential COVID-19 therapeutics: summary of rapid systematic reviews - 30 October 2020

    As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In thi...

    Ongoing Living Update of Potential COVID-19 Therapeutics: summary of rapid systematic reviews - 9 October 2020

    As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In thi...

    Ongoing Living Update of Potential COVID-19 Therapeutics: summary of rapid systematic reviews - 11 August 2020

    More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. In this review we examined 30 therapeutic options. Findings from the RECOVERY Trial showed that low doses of dexamethasone (6 mg of oral or intravenous preparation once daily for 10 days) si...